Recent studies demonstrated that LBX2-AS1 is critically upregulated in most CRC tissues compared with adjacent non-tumor tissues, and LBX2-AS1 expression levels gradually increase in parallel with advanced CRC tumor stages. Here, LBX2 is linked to neoplasm.